Loyola University Medical Center

Gottlieb Memorial Hospital

MacNeal Hospital

Back to homepage
myLoyola

Patrick Joseph Stiff, MD

Hematology, Hematology & Oncology, Internal Medicine, Medical Oncology

Provider Groups

  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact

888-584-7888
Provider Groups

  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact
888-584-7888
Print Share

Services & Specialties

Areas of Specialization

  • Hematology
  • Hematology & Oncology
  • Internal Medicine
  • Medical Oncology

Locations & Contact

Primary Location

Cardinal Bernardin Cancer Center

2160 S First Ave
Maywood , IL 60153

View hours
Monday
7:00am - 6:00pm
Tuesday
7:00am - 6:00pm
Wednesday
7:00am - 6:00pm
Thursday
7:00am - 6:00pm
Friday
7:00am - 6:00pm
Cardinal Bernardin Cancer Center
888-584-7888 View Details

About

Ages Seen

Adults - Over 65
Adults - 18 to 64

Procedures Performed

  • cancer

Additional Resources

Education & Certifications

Education

Education:
Loyola University Stritch School of Medicine (1975)

Residency:
Cleveland Clinic Hospital (1978)

Fellowship:
Memorial Sloan-Kettering Cancer Center (1981)

Board Certifications

Hematology, Hematology, American Board of Internal Medicine Subspecialty (1982)

Medical Oncology, Medical Oncology, American Board of Internal Medicine Subspecialty (1981)

Internal Medicine, Internal Medicine, American Board of (1978)

Provider Groups

Loyola Medicine Physician

Loyola Physician Partners

Publications

  • Randomized Phase III SIERRA Trial of 131I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML. Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Litzow, M. R.; Abboud, C.; Koshy, N.; Stiff, P.; Tomlinson, B.; Abhyankar, S.; Foran, J.; Hari, P.; Chen, G.; Al-Kadhimi, Z.; Kebriaei, P.; Sabloff, M.; Orozco, J. J.; Jamieson, K.; Silverman, M.; Van Besien, K.; Schuster, M.; Law, A. D.; Larkin, K.; Pandit-Taskar, N.; Rowley, S. D.; Munshi, P.; Cook, R.; Levy, M. Y.; Lazarus, H. M.; Sandmaier, B. M.; Pagel, J. M.; Reddy, V.; MacDougall, J.; McNamara, K.; Spross, J.; Haeuber, E.; Vusirikala, M.; Nahar, A.; Desai, A.; Giralt, S.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids. Oluwole, O. O.; Forcade, E.; Muñoz, J.; de Guibert, S.; Vose, J. M.; Bartlett, N. L.; Lin, Y.; Deol, A.; McSweeney, P.; Goy, A. H.; Kersten, M. J.; Jacobson, C. A.; Farooq, U.; Minnema, M. C.; Thieblemont, C.; Timmerman, J. M.; Stiff, P.; Avivi, I.; Tzachanis, D.; Zheng, Y.; Vardhanabhuti, S.; Nater, J.; Shen, R. R.; Miao, H.; Kim, J. J.; van Meerten, T.; Bone marrow transplantation
  • Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma. Hagen, P.; Norton, J.; Tsai, S.; Campo, L.; Lee, M.; Gomez, K.; Stiff, P.; British journal of haematology
  • Pharmacotherapy for the Prevention of Depression and Behavioral Side Effects in Hematopoietic Stem Cell Transplantation Patients. Mumby, P.; Adams, W.; Smith, S.; Rao, M.; Stiff, P.; Transplantation and cellular therapy
  • Nonactivated and IL-7 cultured CD19-specific CAR T cells are enriched in stem cell phenotypes and functionally superior. Wang, S. Y.; Scurti, G. M.; Dalheim, A. V.; Quinn, S.; Stiff, P. J.; Nishimura, M. I.; Blood advances
  • Exopolysaccharide-Treated Dendritic Cells Effectively Ameliorate Acute Graft-versus-Host Disease. Kalinina, O.; Minter, L. M.; Sperling, A. I.; Hollinger, M. K.; Le, P.; Osborne, B. A.; Zhang, S.; Stiff, P.; Knight, K. L.; Transplantation and cellular therapy
  • Selinexor in Combination with Decitabine Attenuates Ovarian Cancer in Mice. Stiff, P. J.; Mehrotra, S.; Potkul, R. K.; Banerjee, S.; Walker, C.; Drakes, M. L.; Cancers
  • Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3. Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; Tzachanis, D.; O'Dwyer, K. M.; Arellano, M. L.; Lin, Y.; Baer, M. R.; Schiller, G. J.; Subklewe, M.; Abedi, M.; Minnema, M. C.; Wierda, W. G.; DeAngelo, D. J.; Stiff, P. J.; Jeyakumar, D.; Mao, D.; Adhikary, S.; Zhou, L.; Schuberth, P. C.; Damico Khalid, R.; Ghobadia, A.; Journal for immunotherapy of cancer
  • Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy. Szabolcs, P.; Mazor, R. D.; Yackoubov, D.; Levy, S.; Stiff, P.; Rezvani, A.; Hanna, R.; Wagner, J.; Keating, A.; Lindemans, C. A.; Karras, N.; McGuirk, J.; Hamerschlak, N.; López-Torija, I.; Sanz, G.; Valcarcel, D.; Horwitz, M. E.; Transplantation and cellular therapy
  • Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial. Crees, Z. D.; Rettig, M. P.; Jayasinghe, R. G.; Stockerl-Goldstein, K.; Larson, S. M.; Arpad, I.; Milone, G. A.; Martino, M.; Stiff, P.; Sborov, D.; Pereira, D.; Micallef, I.; Moreno-Jiménez, G.; Mikala, G.; Coronel, M. L. P.; Holtick, U.; Hiemenz, J.; Qazilbash, M. H.; Hardy, N.; Latif, T.; García-Cadenas, I.; Vainstein-Haras, A.; Sorani, E.; Gliko-Kabir, I.; Goldstein, I.; Ickowicz, D.; Shemesh-Darvish, L.; Kadosh, S.; Gao, F.; Schroeder, M. A.; Vij, R.; DiPersio, J. F.; Nature medicine
  • Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Chakraborty, R.; Yi, J.; Rybicki, L.; Preussler, J.; Deol, A.; Loren, A.; Savani, B.; Jim, H. S. L.; Cerny, J.; Reynolds, J.; Whitten, J.; Wingard, J. R.; McGuirk, J. P.; Uberti, J.; Khera, N.; Stiff, P.; Jaglowski, S. M.; Hashmi, S.; Holtan, S. G.; Devine, S.; Hahn, T.; Whalen, V. L.; Saber, W.; Wood, W.; Baker, K. S.; Syrjala, K.; Majhail, N. S.; Transplantation and cellular therapy
  • Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma. Neelapu, S. S.; Jacobson, C. A.; Ghobadi, A.; Miklos, D. B.; Lekakis, L. J.; Oluwole, O. O.; Lin, Y.; Braunschweig, I.; Hill, B. T.; Timmerman, J. M.; Deol, A.; Reagan, P. M.; Stiff, P.; Flinn, I. W.; Farooq, U.; Goy, A. H.; McSweeney, P. A.; Munoz, J.; Siddiqi, T.; Chavez, J. C.; Herrera, A. F.; Bartlett, N. L.; Bot, A. A.; Shen, R. R.; Dong, J.; Singh, K.; Miao, H.; Kim, J. J.; Zheng, Y.; Locke, F. L.; Blood
  • Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials. Lin, C.; Schwarzbach, A.; Sanz, J.; Montesinos, P.; Stiff, P.; Parikh, S.; Brunstein, C.; Cutler, C.; Lindemans, C. A.; Hanna, R.; Koh, L. P.; Jagasia, M. H.; Valcarcel, D.; Maziarz, R. T.; Keating, A. K.; Hwang, W. Y. K.; Rezvani, A. R.; Karras, N. A.; Fernandes, J. F.; Rocha, V.; Badell, I.; Ram, R.; Schiller, G. J.; Volodin, L.; Walters, M. C.; Hamerschlak, N.; Cilloni, D.; Frankfurt, O.; McGuirk, J. P.; Kurtzberg, J.; Sanz, G.; Simantov, R.; Horwitz, M. E.; Transplantation and cellular therapy
  • Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study. Shah, B. D.; Ghobadi, A.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Cassaday, R. D.; Leguay, T.; Bishop, M. R.; Topp, M. S.; Tzachanis, D.; O'Dwyer, K. M.; Arellano, M. L.; Lin, Y.; Baer, M. R.; Schiller, G. J.; Park, J. H.; Subklewe, M.; Abedi, M.; Minnema, M. C.; Wierda, W. G.; DeAngelo, D. J.; Stiff, P.; Jeyakumar, D.; Dong, J.; Adhikary, S.; Zhou, L.; Schuberth, P. C.; Faghmous, I.; Masouleh, B. K.; Houot, R.; Journal of hematology & oncology
  • Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors. Hong, S.; Zhao, J.; Wang, S.; Wang, H.; Lee, J. H.; Farhadfar, N.; McGuirk, J. P.; Savani, B. N.; Shahrukh, H. K.; Stiff, P.; Khera, N.; Hahn, T.; Loren, A. W.; Jaglowski, S. M.; Wood, W. A.; Saber, W.; Cerny, J.; Holtan, S. G.; Reynolds, J. M.; Deol, A.; Jim, H.; Uberti, J.; Whalen, V.; Yi, J. C.; Preussler, J.; Baker, K. S.; Shaw, B. E.; Devine, S.; Syrjala, K.; Majhail, N. S.; Wingard, J. R.; Al-Mansour, Z.; Transplantation and cellular therapy
  • Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood. Lin, C.; Sajeev, G.; Stiff, P. J.; Brunstein, C. G.; Cutler, C.; Sanz, G.; Lindemans, C. A.; Rezvani, A. R.; Hanna, R.; Koh, L. P.; Maziarz, R. T.; Hwang, W. Y. K.; Song, Y.; Liu, Q.; Manghani, R.; Sivaraman, S.; Signorovitch, J.; Horwitz, M. E.; Sung, A. D.; Transplantation and cellular therapy
  • Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell Transplantation. Rotz, S. J.; Yi, J. C.; Hamilton, B. K.; Wei, W.; Preussler, J. M.; Cerny, J.; Deol, A.; Jim, H.; Khera, N.; Hahn, T.; Hashmi, S. K.; Holtan, S.; Jaglowski, S. M.; Loren, A. W.; McGuirk, J.; Reynolds, J.; Saber, W.; Savani, B. N.; Stiff, P.; Uberti, J.; Wingard, J. R.; Wood, W. A.; Baker, K. S.; Majhail, N. S.; Syrjala, K. L.; Transplantation and cellular therapy
  • COVID-19 thromboembolism incidence, risk factors, and anticoagulation practices from a Chicago metropolitan US population. Berg, S.; Kim, S. H.; Wozniak, A.; Odetola, O.; Arain, S.; Aleem, A.; Coggan, J.; Dave, A.; Elliott, E.; Guerrettaz, R.; Dalal, H.; Lee, R.; Kodali, A.; Moore, P.; Patel, S.; Rajakumar, P.; Qin, S.; Delgado Ramos, G.; Schwartz, C.; Esmail, F.; Feltman Frank, R.; Murchie, E.; Pax, L.; Yun, N.; Zhang, Y.; Barton, K.; Hagen, P.; Hossain, N.; Larson, M. L.; Mai, H.; Nand, S.; Phelan, K.; Venugopal, P.; Stiff, P.; Saraf, S.; American journal of hematology
  • Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation. Riedell, P. A.; Hamadani, M.; Ahn, K. W.; Litovich, C.; Brunstein, C. G.; Cashen, A. F.; Cohen, J. B.; Epperla, N.; Hill, B. T.; Im, A.; Inwards, D. J.; Lister, J.; McCarty, J. M.; Ravi Kiran Pingali, S.; Shadman, M.; Shaughnessy, P.; Solh, M.; Stiff, P. J.; Vose, J. M.; Kharfan-Dabaja, M. A.; Herrera, A. F.; Sauter, C. S.; Smith, S. M.; British journal of haematology
  • Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma. Riedell, P. A.; Hamadani, M.; Ahn, K. W.; Litovich, C.; Murthy, G. S. G.; Locke, F. L.; Brunstein, C. G.; Merryman, R. W.; Stiff, P. J.; Pawarode, A.; Nishihori, T.; Kharfan-Dabaja, M. A.; Herrera, A. F.; Sauter, C. S.; Smith, S. M.; Transplantation and cellular therapy
  • Ovarian Cancer: Therapeutic Strategies to Overcome Immune Suppression. Drakes, M. L.; Stiff, P. J.; Advances in experimental medicine and biology
  • Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Lazaryan, A.; Dolan, M.; Zhang, M. J.; Wang, H. L.; Kharfan-Dabaja, M. A.; Marks, D. I.; Bejanyan, N.; Copelan, E.; Majhail, N. S.; Waller, E. K.; Chao, N.; Prestidge, T.; Nishihori, T.; Kebriaei, P.; Inamoto, Y.; Hamilton, B.; Hashmi, S. K.; Kamble, R. T.; Bacher, U.; Hildebrandt, G. C.; Stiff, P. J.; McGuirk, J.; Aldoss, I.; Beitinjaneh, A. M.; Muffly, L.; Vij, R.; Olsson, R. F.; Byrne, M.; Schultz, K. R.; Aljurf, M.; Seftel, M.; Savoie, M. L.; Savani, B. N.; Verdonck, L. F.; Cairo, M. S.; Hossain, N.; Bhatt, V. R.; Frangoul, H. A.; Abdel-Azim, H.; Al Malki, M.; Munker, R.; Rizzieri, D.; Khera, N.; Nakamura, R.; Ringdén, O.; Van der Poel, M.; Murthy, H. S.; Liu, H.; Mori, S.; De Oliveira, S.; Bolaños-Meade, J.; Elsawy, M.; Barba, P.; Nathan, S.; George, B.; Pawarode, A.; Grunwald, M.; Agrawal, V.; Wang, Y.; Assal, A.; Caro, P. C.; Kuwatsuka, Y.; Seo, S.; Ustun, C.; Politikos, I.; Lazarus, H. M.; Saber, W.; Sandmaier, B. M.; De Lima, M.; Litzow, M.; Bachanova, V.; Weisdorf, D.; Haematologica
  • Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation. de Koning, C.; Tao, W.; Lacna, A.; van Veghel, K.; Horwitz, M. E.; Sanz, G.; Jagasia, M. H.; Wagner, J. E.; Stiff, P. J.; Hanna, R.; Cilloni, D.; Valcárcel, D.; Peled, T.; Galamidi Cohen, E.; Goshen, U.; Pandit, A.; Lindemans, C. A.; Jan Boelens, J.; Nierkens, S.; Bone marrow transplantation
  • Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma. Oluwole, O. O.; Bouabdallah, K.; Muñoz, J.; De Guibert, S.; Vose, J. M.; Bartlett, N. L.; Lin, Y.; Deol, A.; McSweeney, P. A.; Goy, A. H.; Kersten, M. J.; Jacobson, C. A.; Farooq, U.; Minnema, M. C.; Thieblemont, C.; Timmerman, J. M.; Stiff, P.; Avivi, I.; Tzachanis, D.; Kim, J. J.; Bashir, Z.; McLeroy, J.; Zheng, Y.; Rossi, J. M.; Johnson, L.; Goyal, L.; van Meerten, T.; British journal of haematology
  • A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies. Saber, W.; Steinert, P.; Zhang, M. J.; Chen, M.; Pope, A.; Keating, A.; Wingard, J. R.; Ballen, K.; Stiff, P.; Perales, M. A.; Forman, S.; Champlin, R.; Langston, A.; Rudebeck, M.; Horowitz, M.; Transplantation and cellular therapy
  • Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study. Horwitz, M. E.; Stiff, P. J.; Cutler, C.; Brunstein, C.; Hanna, R.; Maziarz, R. T.; Rezvani, A. R.; Karris, N. A.; McGuirk, J.; Valcarcel, D.; Schiller, G. J.; Lindemans, C. A.; Hwang, W. Y. K.; Koh, L. P.; Keating, A.; Khaled, Y.; Hamerschlak, N.; Frankfurt, O.; Peled, T.; Segalovich, I.; Blackwell, B.; Wease, S.; Freedman, L. S.; Galamidi-Cohen, E.; Sanz, G.; Blood
  • Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia. Desai, P. M.; Brown, J.; Gill, S.; Solh, M. M.; Akard, L. P.; Hsu, J. W.; Ustun, C.; Andreadis, C.; Frankfurt, O.; Foran, J. M.; Lister, J.; Schiller, G. J.; Wieduwilt, M. J.; Pagel, J. M.; Stiff, P. J.; Liu, D.; Khan, I.; Stock, W.; Kambhampati, S.; Tallman, M. S.; Morris, L.; Edwards, J.; Pusic, I.; Kantarjian, H. M.; Mamelok, R.; Wong, A.; Van Syoc, R.; Kellerman, L.; Panuganti, S.; Mandalam, R.; Abboud, C. N.; Ravandi, F.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study. Shah, B. D.; Ghobadi, A.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Cassaday, R. D.; Leguay, T.; Bishop, M. R.; Topp, M. S.; Tzachanis, D.; O'Dwyer, K. M.; Arellano, M. L.; Lin, Y.; Baer, M. R.; Schiller, G. J.; Park, J. H.; Subklewe, M.; Abedi, M.; Minnema, M. C.; Wierda, W. G.; DeAngelo, D. J.; Stiff, P.; Jeyakumar, D.; Feng, C.; Dong, J.; Shen, T.; Milletti, F.; Rossi, J. M.; Vezan, R.; Masouleh, B. K.; Houot, R.; Lancet (London, England)
  • Expanding the Toolbox of Adoptive Cell Immunotherapy. Hossain, N. M.; Stiff, P. J.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Immune Checkpoint Blockade in Gynecologic Cancers: State of Affairs. Drakes, M. L.; Czerlanis, C. M.; Stiff, P. J.; Cancers
  • Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia. Uy, G. L.; Aldoss, I.; Foster, M. C.; Sayre, P. H.; Wieduwilt, M. J.; Advani, A. S.; Godwin, J. E.; Arellano, M. L.; Sweet, K. L.; Emadi, A.; Ravandi, F.; Erba, H. P.; Byrne, M.; Michaelis, L.; Topp, M. S.; Vey, N.; Ciceri, F.; Carrabba, M. G.; Paolini, S.; Huls, G. A.; Jongen-Lavrencic, M.; Wermke, M.; Chevallier, P.; Gyan, E.; Récher, C.; Stiff, P. J.; Pettit, K. M.; Löwenberg, B.; Church, S. E.; Anderson, E.; Vadakekolathu, J.; Santaguida, M.; Rettig, M. P.; Muth, J.; Curtis, T.; Fehr, E.; Guo, K.; Zhao, J.; Bakkacha, O.; Jacobs, K.; Tran, K.; Kaminker, P.; Kostova, M.; Bonvini, E.; Walter, R. B.; Davidson-Moncada, J. K.; Rutella, S.; DiPersio, J. F.; Blood
  • Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen. Hagen, P.; D'Souza, A.; Hari, P.; Davila, O.; Zhang, M. J.; Vesole, D. H.; Smith, S. E.; Rodriguez, T. E.; Stiff, P. J.; Leukemia & lymphoma
  • A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients. Chemaly, R. F.; Dadwal, S. S.; Bergeron, A.; Ljungman, P.; Kim, Y. J.; Cheng, G. S.; Pipavath, S. N.; Limaye, A. P.; Blanchard, E.; Winston, D. J.; Stiff, P. J.; Zuckerman, T.; Lachance, S.; Rahav, G.; Small, C. B.; Mullane, K. M.; Patron, R. L.; Lee, D. G.; Hirsch, H. H.; Waghmare, A.; McKevitt, M.; Jordan, R.; Guo, Y.; German, P.; Porter, D. P.; Gossage, D. L.; Watkins, T. R.; Marty, F. M.; Chien, J. W.; Boeckh, M.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Lazaryan, A.; Dolan, M.; Zhang, M. J.; Wang, H. L.; Kharfan-Dabaja, M. A.; Marks, D. I.; Bejanyan, N.; Copelan, E.; Majhail, N. S.; Waller, E. K.; Chao, N.; Prestidge, T.; Nishihori, T.; Kebriaei, P.; Inamoto, Y.; Hamilton, B.; Hashmi, S. K.; Kamble, R. T.; Bacher, U.; Hildebrandt, G. C.; Stiff, P. J.; McGuirk, J.; Aldoss, I.; Beitinjaneh, A. M.; Muffly, L.; Vij, R.; Olsson, R. F.; Byrne, M.; Schultz, K. R.; Aljurf, M.; Seftel, M.; Savoie, M. L.; Savani, B. N.; Verdonck, L. F.; Cairo, M. S.; Hossain, N.; Bhatt, V. R.; Frangoul, H. A.; Abdel-Azim, H.; Malki, M. A.; Munker, R.; Rizzieri, D.; Khera, N.; Nakamura, R.; Ringdén, O.; van der Poel, M.; Murthy, H. S.; Liu, H.; Mori, S.; De Oliveira, S.; Bolaños-Meade, J.; Elsawy, M.; Barba, P.; Nathan, S.; George, B.; Pawarode, A.; Grunwald, M.; Agrawal, V.; Wang, Y.; Assal, A.; Caro, P. C.; Kuwatsuka, Y.; Seo, S.; Ustun, C.; Politikos, I.; Lazarus, H. M.; Saber, W.; Sandmaier, B. M.; De Lima, M.; Litzow, M.; Bachanova, V.; Weisdorf, D.; Acute Leukemia Committee of the CIBMTR; Haematologica
  • Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis. Al-Mansour, Z.; Li, H.; Cook, J. R.; Constine, L. S.; Couban, S.; Stewart, D. A.; Shea, T. C.; Porcu, P.; Winter, J. N.; Kahl, B. S.; Smith, S. M.; Marcellus, D. C.; Barton, K. P.; Mills, G. M.; LeBlanc, M.; Rimsza, L. M.; Forman, S. J.; Leonard, J. P.; Fisher, R. I.; Friedberg, J. W.; Stiff, P. J.; Leukemia & lymphoma
  • Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide. Horwitz, M. E.; Wease, S.; Blackwell, B.; Valcarcel, D.; Frassoni, F.; Boelens, J. J.; Nierkens, S.; Jagasia, M.; Wagner, J. E.; Kuball, J.; Koh, L. P.; Majhail, N. S.; Stiff, P. J.; Hanna, R.; Hwang, W. Y. K.; Kurtzberg, J.; Cilloni, D.; Freedman, L. S.; Montesinos, P.; Sanz, G.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • The Role of Salvage Second Autologous Hematopoietic Cell Transplantation in Relapsed Multiple Myeloma. Hagen, P. A.; Stiff, P.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial. Locke, F. L.; Ghobadi, A.; Jacobson, C. A.; Miklos, D. B.; Lekakis, L. J.; Oluwole, O. O.; Lin, Y.; Braunschweig, I.; Hill, B. T.; Timmerman, J. M.; Deol, A.; Reagan, P. M.; Stiff, P.; Flinn, I. W.; Farooq, U.; Goy, A.; McSweeney, P. A.; Munoz, J.; Siddiqi, T.; Chavez, J. C.; Herrera, A. F.; Bartlett, N. L.; Wiezorek, J. S.; Navale, L.; Xue, A.; Jiang, Y.; Bot, A.; Rossi, J. M.; Kim, J. J.; Go, W. Y.; Neelapu, S. S.; The Lancet. Oncology
  • Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors. Majhail, N. S.; Murphy, E.; Laud, P.; Preussler, J. M.; Denzen, E. M.; Abetti, B.; Adams, A.; Besser, R.; Burns, L. J.; Cerny, J.; Drexler, R.; Hahn, T.; Idossa, L.; Jahagirdar, B.; Kamani, N.; Loren, A.; Mattila, D.; McGuirk, J.; Moore, H.; Reynolds, J.; Saber, W.; Salazar, L.; Schatz, B.; Stiff, P.; Wingard, J. R.; Syrjala, K. L.; Baker, K. S.; Haematologica
  • Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse. Moskowitz, C. H.; Walewski, J.; Nademanee, A.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M. H.; Chen, A. I.; Stiff, P.; Viviani, S.; Bachanova, V.; Sureda, A.; McClendon, T.; Lee, C.; Lisano, J.; Sweetenham, J.; Blood
  • Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment. Drakes, M. L.; Stiff, P. J.; Cancers
  • Low mean post-transplantation tacrolimus levels in weeks 2-3 correlate with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation from related and unrelated donors. Hagen, P. A.; Adams, W.; Smith, S.; Tsai, S.; Stiff, P.; Bone marrow transplantation
  • A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation. Mullane, K. M.; Winston, D. J.; Nooka, A.; Morris, M. I.; Stiff, P.; Dugan, M. J.; Holland, H.; Gregg, K.; Adachi, J. A.; Pergam, S. A.; Alexander, B. D.; Dubberke, E. R.; Broyde, N.; Gorbach, S. L.; Sears, P. S.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • Safety Analysis of Brentuximab Vedotin from the Phase III AETHERA Trial in Hodgkin Lymphoma in the Post-Transplant Consolidation Setting. Nademanee, A.; Sureda, A.; Stiff, P.; Holowiecki, J.; Abidi, M.; Hunder, N.; Pecsok, M.; Uttarwar, M.; Purevjal, I.; Sweetenham, J.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer. Drakes, M. L.; Mehrotra, S.; Aldulescu, M.; Potkul, R. K.; Liu, Y.; Grisoli, A.; Joyce, C.; O'Brien, T. E.; Stack, M. S.; Stiff, P. J.; Journal of ovarian research
  • Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation. Stiff, P. J.; Montesinos, P.; Peled, T.; Landau, E.; Goudsmid, N. R.; Mandel, J.; Hasson, N.; Olesinski, E.; Glukhman, E.; Snyder, D. A.; Cohen, E. G.; Kidron, O. S.; Bracha, D.; Harati, D.; Ben-Abu, K.; Freind, E.; Freedman, L. S.; Cohen, Y. C.; Olmer, L.; Barishev, R.; Rocha, V.; Gluckman, E.; Horowitz, M. M.; Eapen, M.; Nagler, A.; Sanz, G.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report. Micallef, I. N.; Stiff, P. J.; Nademanee, A. P.; Maziarz, R. T.; Horwitz, M. E.; Stadtmauer, E. A.; Kaufman, J. L.; McCarty, J. M.; Vargo, R.; Cheverton, P. D.; Struijs, M.; Bolwell, B.; DiPersio, J. F.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703). Smith, E. P.; Li, H.; Friedberg, J. W.; Constine, L. S.; Rimsza, L. M.; Cook, J. R.; Laport, G. G.; Popplewell, L. L.; Holmberg, L. A.; Smith, S. M.; LeBlanc, M.; Forman, S. J.; Fisher, R. I.; Stiff, P. J.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells. Moore, T.; Wagner, C. R.; Scurti, G. M.; Hutchens, K. A.; Godellas, C.; Clark, A. L.; Kolawole, E. M.; Hellman, L. M.; Singh, N. K.; Huyke, F. A.; Wang, S. Y.; Calabrese, K. M.; Embree, H. D.; Orentas, R.; Shirai, K.; Dellacecca, E.; Garrett-Mayer, E.; Li, M.; Eby, J. M.; Stiff, P. J.; Evavold, B. D.; Baker, B. M.; Le Poole, I. C.; Dropulic, B.; Clark, J. I.; Nishimura, M. I.; Cancer immunology, immunotherapy : CII
  • Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma. Neelapu, S. S.; Locke, F. L.; Bartlett, N. L.; Lekakis, L. J.; Miklos, D. B.; Jacobson, C. A.; Braunschweig, I.; Oluwole, O. O.; Siddiqi, T.; Lin, Y.; Timmerman, J. M.; Stiff, P. J.; Friedberg, J. W.; Flinn, I. W.; Goy, A.; Hill, B. T.; Smith, M. R.; Deol, A.; Farooq, U.; McSweeney, P.; Munoz, J.; Avivi, I.; Castro, J. E.; Westin, J. R.; Chavez, J. C.; Ghobadi, A.; Komanduri, K. V.; Levy, R.; Jacobsen, E. D.; Witzig, T. E.; Reagan, P.; Bot, A.; Rossi, J.; Navale, L.; Jiang, Y.; Aycock, J.; Elias, M.; Chang, D.; Wiezorek, J.; Go, W. Y.; The New England journal of medicine
  • Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells. Moore, T.; Wagner, C. R.; Scurti, G. M.; Hutchens, K. A.; Godellas, C.; Clark, A. L.; Kolawole, E. M.; Hellman, L. M.; Singh, N. K.; Huyke, F. A.; Wang, S. Y.; Calabrese, K. M.; Embree, H. D.; Orentas, R.; Shirai, K.; Dellacecca, E.; Garrett-Mayer, E.; Li, M.; Eby, J. M.; Stiff, P. J.; Evavold, B. D.; Baker, B. M.; Le Poole, I. C.; Dropulic, B.; Clark, J. I.; Nishimura, M. I.; Cancer immunology, immunotherapy : CII
  • Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation. Soiffer, R. J.; Kim, H. T.; McGuirk, J.; Horwitz, M. E.; Johnston, L.; Patnaik, M. M.; Rybka, W.; Artz, A.; Porter, D. L.; Shea, T. C.; Boyer, M. W.; Maziarz, R. T.; Shaughnessy, P. J.; Gergis, U.; Safah, H.; Reshef, R.; DiPersio, J. F.; Stiff, P. J.; Vusirikala, M.; Szer, J.; Holter, J.; Levine, J. D.; Martin, P. J.; Pidala, J. A.; Lewis, I. D.; Ho, V. T.; Alyea, E. P.; Ritz, J.; Glavin, F.; Westervelt, P.; Jagasia, M. H.; Chen, Y. B.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis. Kanate, A. S.; DiGilio, A.; Ahn, K. W.; Al Malki, M.; Jacobsen, E.; Steinberg, A.; Hamerschlak, N.; Kharfan-Dabaja, M.; Salit, R.; Ball, E.; Bashir, Q.; Cashen, A.; Couriel, D.; Diez-Martin, J.; Katsanis, E.; Linhares, Y.; Mori, S.; Nash, R.; Pawarode, A.; Perales, M. A.; Phipps, C. D.; Richman, C.; Savani, B. N.; Shapira, M. Y.; Stiff, P.; Strair, R.; Fenske, T. S.; Smith, S. M.; Sureda, A.; Olteanu, H.; Hamadani, M.; British journal of haematology
  • Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma. Ramsey, S. D.; Nademanee, A.; Masszi, T.; Holowiecki, J.; Abidi, M.; Chen, A.; Stiff, P.; Viviani, S.; Sweetenham, J. W.; Radford, J.; Zhu, Y.; Bonthapally, V.; Thomas, E.; Richhariya, A.; Hunder, N. N.; Walewski, J.; Moskowitz, C. H.; British journal of haematology
  • Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in mice. Xin, J.; Breslin, P.; Wei, W.; Li, J.; Gutierrez, R.; Cannova, J.; Ni, A.; Ng, G.; Schmidt, R.; Chen, H.; Parini, V.; Kuo, P. C.; Kini, A. R.; Stiff, P.; Zhu, J.; Zhang, J.; Haematologica
  • Allografts for Follicular Non-Hodgkin Lymphoma: Why Never Is No Longer an Acceptable Answer. Stiff, P. J.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. Rodriguez, T. E.; Hari, P.; Stiff, P. J.; Smith, S. E.; Sterrenberg, D.; Vesole, D. H.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Understanding dendritic cell immunotherapy in ovarian cancer. Drakes, M. L.; Stiff, P. J.; Expert review of anticancer therapy
  • Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704. Puvvada, S. D.; Stiff, P. J.; Leblanc, M.; Cook, J. R.; Couban, S.; Leonard, J. P.; Kahl, B.; Marcellus, D.; Shea, T. C.; Winter, J. N.; Li, H.; Rimsza, L. M.; Friedberg, J. W.; Smith, S. M.; British journal of haematology
  • A 54-Year-Old Woman with Donor Cell Origin of Multiple Myeloma after Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of CML. Maestas, E.; Jain, S.; Stiff, P.; Case reports in hematology
  • What is the role of autologous transplant for lymphoma in the current era? Stiff, P.; Hematology. American Society of Hematology. Education Program
  • Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer. Catenacci, D. V.; Junttila, M. R.; Karrison, T.; Bahary, N.; Horiba, M. N.; Nattam, S. R.; Marsh, R.; Wallace, J.; Kozloff, M.; Rajdev, L.; Cohen, D.; Wade, J.; Sleckman, B.; Lenz, H. J.; Stiff, P.; Kumar, P.; Xu, P.; Henderson, L.; Takebe, N.; Salgia, R.; Wang, X.; Stadler, W. M.; de Sauvage, F. J.; Kindler, H. L.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era. Diefenbach, C. S.; Li, H.; Hong, F.; Gordon, L. I.; Fisher, R. I.; Bartlett, N. L.; Crump, M.; Gascoyne, R. D.; Wagner, H.; Stiff, P. J.; Cheson, B. D.; Stewart, D. A.; Kahl, B. S.; Friedberg, J. W.; Blum, K. A.; Habermann, T. M.; Tuscano, J. M.; Hoppe, R. T.; Horning, S. J.; Advani, R. H.; British journal of haematology
  • Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis. Stiff, P. J.; Leinonen, M.; Kullenberg, T.; Rudebeck, M.; de Chateau, M.; Spielberger, R.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma. Bachanova, V.; Burns, L. J.; Ahn, K. W.; Laport, G. G.; Akpek, G.; Kharfan-Dabaja, M. A.; Nishihori, T.; Agura, E.; Armand, P.; Jaglowski, S. M.; Cairo, M. S.; Cashen, A. F.; Cohen, J. B.; D'Souza, A.; Freytes, C. O.; Gale, R. P.; Ganguly, S.; Ghosh, N.; Holmberg, L. A.; Inwards, D. J.; Kanate, A. S.; Lazarus, H. M.; Malone, A. K.; Munker, R.; Mussetti, A.; Norkin, M.; Prestidge, T. D.; Rowe, J. M.; Satwani, P.; Siddiqi, T.; Stiff, P. J.; William, B. M.; Wirk, B.; Maloney, D. G.; Smith, S. M.; Sureda, A. M.; Carreras, J.; Hamadani, M.; Center for International Blood and Marrow Transplant Research Lymphoma Working Committee; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial. Advani, R. H.; Hong, F.; Fisher, R. I.; Bartlett, N. L.; Robinson, K. S.; Gascoyne, R. D.; Wagner, H.; Stiff, P. J.; Cheson, B. D.; Stewart, D. A.; Gordon, L. I.; Kahl, B. S.; Friedberg, J. W.; Blum, K. A.; Habermann, T. M.; Tuscano, J. M.; Hoppe, R. T.; Horning, S. J.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial. Moskowitz, C. H.; Nademanee, A.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M. H.; Chen, A. I.; Stiff, P.; Gianni, A. M.; Carella, A.; Osmanov, D.; Bachanova, V.; Sweetenham, J.; Sureda, A.; Huebner, D.; Sievers, E. L.; Chi, A.; Larsen, E. K.; Hunder, N. N.; Walewski, J.; AETHERA Study Group; Lancet (London, England)
  • Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy. Othus, M.; Appelbaum, F. R.; Petersdorf, S. H.; Kopecky, K. J.; Slovak, M.; Nevill, T.; Brandwein, J.; Larson, R. A.; Stiff, P. J.; Walter, R. B.; Tallman, M. S.; Stenke, L.; Erba, H. P.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Donor cell myeloid sarcoma. Walshauser, M. A.; Go, A.; Sojitra, P.; Venkataraman, G.; Stiff, P.; Case reports in hematology
  • Clinical significance of MYC expression and/or "high-grade" morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study. Cook, J. R.; Goldman, B.; Tubbs, R. R.; Rimsza, L.; Leblanc, M.; Stiff, P.; Fisher, R.; The American journal of surgical pathology
  • The role of body mass index in survival outcome for lymphoma patients: US intergroup experience. Hong, F.; Habermann, T. M.; Gordon, L. I.; Hochster, H.; Gascoyne, R. D.; Morrison, V. A.; Fisher, R. I.; Bartlett, N. L.; Stiff, P. J.; Cheson, B. D.; Crump, M.; Horning, S. J.; Kahl, B. S.; Annals of oncology : official journal of the European Society for Medical Oncology
  • Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy. Drakes, M. L.; Stiff, P. J.; ImmunoTargets and therapy
  • Neurologic aspects of plasma cell disorders. Sobol, U.; Stiff, P.; Handbook of clinical neurology
  • Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma. Stiff, P. J.; Unger, J. M.; Cook, J. R.; Constine, L. S.; Couban, S.; Stewart, D. A.; Shea, T. C.; Porcu, P.; Winter, J. N.; Kahl, B. S.; Miller, T. P.; Tubbs, R. R.; Marcellus, D.; Friedberg, J. W.; Barton, K. P.; Mills, G. M.; LeBlanc, M.; Rimsza, L. M.; Forman, S. J.; Fisher, R. I.; The New England journal of medicine
  • Seven-year follow-up of allogeneic transplant using BCNU, etoposide, cytarabine and melphalan chemotherapy in patients with Hodgkin lymphoma after autograft failure: importance of minimal residual disease. Sobol, U.; Rodriguez, T.; Smith, S.; Go, A.; Vimr, R.; Parthasarathy, M.; Guo, R.; Stiff, P.; Leukemia & lymphoma
  • Salvage second hematopoietic cell transplantation in myeloma. Michaelis, L. C.; Saad, A.; Zhong, X.; Le-Rademacher, J.; Freytes, C. O.; Marks, D. I.; Lazarus, H. M.; Bird, J. M.; Holmberg, L.; Kamble, R. T.; Kumar, S.; Lill, M.; Meehan, K. R.; Saber, W.; Schriber, J.; Tay, J.; Vogl, D. T.; Wirk, B.; Savani, B. N.; Gale, R. P.; Vesole, D. H.; Schiller, G. J.; Abidi, M.; Anderson, K. C.; Nishihori, T.; Kalaycio, M. E.; Vose, J. M.; Moreb, J. S.; Drobyski, W.; Munker, R.; Roy, V.; Ghobadi, A.; Holland, H. K.; Nath, R.; To, L. B.; Maiolino, A.; Kassim, A. A.; Giralt, S. A.; Landau, H.; Schouten, H. C.; Maziarz, R. T.; Mikhael, J.; Kindwall-Keller, T.; Stiff, P. J.; Gibson, J.; Lonial, S.; Krishnan, A.; Dispenzieri, A.; Hari, P.; Plasma Cell Disorders Working Committee of the Center for International Blood and Marrow Transplant Research; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Dendritic cell immunotherapy in ovarian cancer. Stiff, P. J.; Czerlanis, C.; Drakes, M. L.; Expert review of anticancer therapy
  • A potential role for B cells in suppressed immune responses in cord blood transplant recipients. Beaudette-Zlatanova, B. C.; Le, P. T.; Knight, K. L.; Zhang, S.; Zakrzewski, S.; Parthasarathy, M.; Stiff, P. J.; Bone marrow transplantation
  • Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants. Mumby, P. B.; Hurley, C.; Samsi, M.; Thilges, S.; Parthasarathy, M.; Stiff, P. J.; Bone marrow transplantation
  • A human thymic epithelial cell culture system for the promotion of lymphopoiesis from hematopoietic stem cells. Beaudette-Zlatanova, B. C.; Knight, K. L.; Zhang, S.; Stiff, P. J.; Zúñiga-Pflücker, J. C.; Le, P. T.; Experimental hematology
  • Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma. Stiff, P. J.; Micallef, I.; Nademanee, A. P.; Stadtmauer, E. A.; Maziarz, R. T.; Bolwell, B. J.; Bridger, G.; Marulkar, S.; Hsu, F. J.; DiPersio, J. F.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation. Gerds, A.; Fox-Geiman, M.; Dawravoo, K.; Rodriguez, T.; Toor, A.; Smith, S.; Kiley, K.; Fletcher-Gonzalez, D.; Hicks, C.; Stiff, P.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma. Stiff, P. J.; Agovi, M. A.; Antman, K. H.; Blaise, D.; Camitta, B. M.; Cairo, M. S.; Childs, R. W.; Edwards, J. R.; Gale, R. P.; Hale, G. A.; Lazarus, H. M.; Arora, M.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Inverse relationship between dendritic cell CCR9 expression and maturation state. Drakes, M. L.; Stiff, P. J.; Blanchard, T. G.; Immunology
  • Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors. Stiff, P. J.; Bensinger, W.; Abidi, M. H.; Gingrich, R.; Artz, A. S.; Nademanee, A.; Hansen, K. S.; Sobczak, C.; Cutler, C.; Bolwell, B.; Shore, T. B.; Lazarus, H. M.; Yeager, A. M.; Lovelace, W.; Guo, M.; Dreiling, L.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Guo, Y.; Niu, C.; Breslin, P.; Tang, M.; Zhang, S.; Wei, W.; Kini, A. R.; Paner, G. P.; Alkan, S.; Morris, S. W.; Diaz, M.; Stiff, P. J.; Zhang, J.; Blood
  • Managing hematopoietic stem-cell transplant resources: the case for outpatient transplantation. Stiff, P. J.; Leukemia & lymphoma
  • Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient. Stiff, P.; Micallef, I.; McCarthy, P.; Magalhaes-Silverman, M.; Weisdorf, D.; Territo, M.; Badel, K.; Calandra, G.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial. Nand, S.; Godwin, J.; Smith, S.; Barton, K.; Michaelis, L.; Alkan, S.; Veerappan, R.; Rychlik, K.; Germano, E.; Stiff, P.; Leukemia & lymphoma
  • Mucositis: continuing progress for a continuing need. Stiff, P. J.; The journal of supportive oncology
  • The administration of polymerized human hemoglobin (Pyridoxylated) to a Jehovah's Witness after submyeloablative stem cell transplantation complicated by delayed graft failure. Smith, S. E.; Toor, A.; Rodriguez, T.; Stiff, P.; Comprehensive therapy
  • Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activity. Toor, A. A.; Stiff, P. J.; Nickoloff, B. J.; Rodriguez, T.; Klein, J. L.; Gordon, K. B.; The Journal of dermatological treatment
  • Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Hofmeister, C. C.; Zhang, J.; Knight, K. L.; Le, P.; Stiff, P. J.; Bone marrow transplantation
  • Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation. Stiff, P. J.; Miller, L. A.; Mumby, P.; Kiley, K.; Batiste, R.; Porter, N.; Potocki, K.; Volle, M.; Lichtenstein, S.; Wojtowicz, S.; Zakrzewski, S.; Toor, A.; Rodriguez, T.; Bone marrow transplantation
  • Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Stiff, P. J.; Erder, H.; Bensinger, W. I.; Emmanouilides, C.; Gentile, T.; Isitt, J.; Lu, Z. J.; Spielberger, R.; Bone marrow transplantation
  • Mucosal protection by cytokines. Hofmeister, C. C.; Stiff, P. J.; Current hematology reports
  • Recurrent steroid-responsive pancreatitis associated with myelodysplastic syndrome and transformations. Tanvetyanon, T.; Stiff, P. J.; Leukemia & lymphoma
  • Second allografts for relapsed hematologic malignancies: feasibility of using a different donor. Duus, J. E.; Stiff, P. J.; Choi, J.; Parthasarathy, M.; Rodriguez, T.; Toor, A. A.; Bone marrow transplantation
  • Post-transplant air-leak syndrome. Tanvetyanon, T.; Toor, A. A.; Stiff, P. J.; British journal of haematology
  • Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study. Stiff, P. J.; Shpall, E. J.; Liu, P. Y.; Wilczynski, S. P.; Callander, N. S.; Scudder, S. A.; Jazieh, A. R.; Samlowski, W.; McCoy, J.; Alberts, D. S.; Southwest Oncology Group Study; Gynecologic oncology
  • Graft-versus-host disease of the skin: life and death on the epidermal edge. Hofmeister, C. C.; Quinn, A.; Cooke, K. R.; Stiff, P.; Nickoloff, B.; Ferrara, J. L.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost. Boeve, S.; Strupeck, J.; Creech, S.; Stiff, P. J.; Bone marrow transplantation
  • Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myeloma. Toor, A. A.; Ayers, J.; Strupeck, J.; Parthasarathy, M.; Creech, S.; Rodriguez, T.; Stiff, P. J.; British journal of haematology
  • The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial. Stiff, P. J.; Unger, J. M.; Forman, S. J.; McCall, A. R.; LeBlanc, M.; Nademanee, A. P.; Bolwell, B. J.; Fisher, R. I.; Southwest Oncology Group; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Current treatment results of allogeneic bone marrow transplantation for acute myeloid and lymphoid leukemia. Rodriguez, T. E.; Stiff, P. J.; Current hematology reports
  • BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective. Cooney, J. P.; Stiff, P. J.; Toor, A. A.; Parthasarathy, M.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report. Stiff, P. J.; Veum-Stone, J.; Lazarus, H. M.; Ayash, L.; Edwards, J. R.; Keating, A.; Klein, J. P.; Oblon, D. J.; Shea, T. C.; Thomé, S.; Horowitz, M. M.; Annals of internal medicine
  • Radiologic case study. Bone marrow transplant and multiple sites of osteonecrosis. Simon, J.; Lomasney, L. M.; Demos, T. C.; Stiff, P. J.; Orthopedics
  • Management strategies for the hard-to-mobilize patient. Stiff, P. J.; Bone marrow transplantation
  • Blood and marrow transplantation in relapsed or refractory non-Hodgkin's lymphoma. Stiff, P. J.; Oncology (Williston Park, N.Y.)
  • Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial. Stiff, P. J.; Dahlberg, S.; Forman, S. J.; McCall, A. R.; Horning, S. J.; Nademanee, A. P.; Blume, K. G.; LeBlanc, M.; Fisher, R. I.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. Stiff, P. J.; Bayer, R.; Kerger, C.; Potkul, R. K.; Malhotra, D.; Peace, D. J.; Smith, D.; Fisher, S. G.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial. Stiff, P. J.; Bayer, R.; Tan, S.; Camarda, M.; Sosman, J.; Peace, D.; Kinch, L.; Rad, N.; Loutfi, S.; Clinical cancer research : an official journal of the American Association for Cancer Research
  • A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy. Sosman, J. A.; Stiff, P. J.; Bayer, R. A.; Peliska, J.; Peace, D. J.; Loutfi, S.; Stock, W.; Oldenburg, D.; Unverzagt, K.; Bender, J.; Bone marrow transplantation
  • Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma. Stiff, P. J.; McKenzie, R. S.; Alberts, D. S.; Sosman, J. A.; Dolan, J. R.; Rad, N.; McCloskey, T.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Cytotoxic synergy of cisplatin with concurrent hydroxyurea and cytarabine: summary of an in vitro model and initial clinical pilot experience. Albain, K. S.; Swinnen, L. J.; Erickson, L. C.; Stiff, P. J.; Fisher, S. G.; Fisher, R. I.; Seminars in oncology
  • A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study. Stiff, P. J.; McKenzie, R. S.; Potempa, L. D.; Albain, K.; Koch, D.; Braud, E.; Bansal, V. K.; Weidner, M. K.; Lanzotti, V. J.; Chun, H. G.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Anti-CD33 monoclonal antibody and etoposide/cytosine arabinoside combinations for the ex vivo purification of bone marrow in acute nonlymphocytic leukemia. Stiff, P. J.; Schulz, W. C.; Bishop, M.; Marks, L.; Blood
  • Treatment options for recurrent lymphomas. Fisher, R. I.; Stiff, P. J.; Seminars in oncology
  • Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model. Albain, K. S.; Swinnen, L. J.; Erickson, L. C.; Stiff, P. J.; Fisher, R. I.; Cancer chemotherapy and pharmacology
  • Autologous stem cell transplantation using peripheral blood stem cells. Stiff, P. J.; Koester, A. R.; Eagleton, L. E.; Hindman, T.; Braud, E.; Weidner, M. K.; Transplantation
  • Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing. Stiff, P. J.; Koester, A. R.; Weidner, M. K.; Dvorak, K.; Fisher, R. I.; Blood
888-584-7888

Dismiss Modal

Close 

Where would you like to share?